Recombinant adeno‐associated viruses (rAAV) are among the most promising vectors for long‐term gene transduction. These viruses have a high degree of safety, making them ideal for gene therapy applications. Significant progress has been made in improving rAAV vector production and purification. In this webcast, we present a study exploring different chromatography workflow solutions to purify rAAV8.
Experimental conditions and data will be presented on using anion exchange (AEX) and mixed-mode chromatography to purify rAAV8.
Key takeaways:
- Increased efficiencies using AEX for capture
- Mixed-mode chromatography used to separate empty capsid from full capsid and remove DNA
- More flexible, economical purification workflow compared to traditional purification process
Learn more at www.bio-rad.com/library
We Are Bio-Rad.
Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.
Connect with Bio-Rad Online:
Website: www.bio-rad.com/
LinkedIn: / 1613226
Facebook: / biorad
Twitter: / bioradlifesci
Instagram: @BioRadLabs
Snapchat: @BioRadLabs
©2024 Bio-Rad is a trademark of Bio-Rad Laboratories, Inc. in certain jurisdictions. All trademarks used herein are the property of their respective owner.
Music used by permission granted by royalty-free license from Pond5.com